Literature DB >> 20582965

High health-related quality of life among long-term survivors of childhood acute lymphoblastic leukemia.

Marika J Harila1, Jarmo Salo, Marjatta Lanning, Ilpo Vilkkumaa, Arja H Harila-Saari.   

Abstract

BACKGROUND: Health-related quality of life (HRQoL) was assessed in a cohort of long-term childhood acute lymphoblastic leukemia (ALL) survivors. PROCEDURE: Rand-36-Item health Survey (RAND-36) was used to assess subjective HRQoL in 74 survivors of ALL an average of 20 years after the diagnosis. Cranial irradiation had been administered to 46 of the survivors, while 28 survivors had solely been treated with chemotherapy. The control group consisted of 146 healthy young adults selected from local population registry. Survivors were examined by a physician and late effects were graded using the Common Terminology Criteria for Adverse Events (CTCAEv3).
RESULTS: ALL survivors achieved significantly higher scores than the controls on three of the eight HRQoL subscales; role limitations due to emotional problems (P = 0.030), mental health (P = 0.030) and vitality (P = 0.004). In comparison to controls, survivors with a follow-up of more than 20 years had significantly higher scores on vitality (P = 0.006) and mental health (P = 0.011). Survivors with severe (grade 3 and 4) late effects scored significantly better than controls on vitality (P = 0.043) and mental health (P = 0.040). Patients who had been treated for an ALL relapse and had received the most intensive chemo- and radiotherapy had significantly higher scores on mental health (P = 0.004) and vitality (P = 0.004) than the controls.
CONCLUSIONS: Long-term survivors of childhood ALL reported equal or better HRQoL in RAND-36. Higher HRQoL scores were associated with more severe late effects and intensive therapy. Our findings support the idea of response bias. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20582965     DOI: 10.1002/pbc.22531

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  16 in total

Review 1.  Late effects of childhood leukemia therapy.

Authors:  Joy M Fulbright; Sripriya Raman; Wendy S McClellan; Keith J August
Journal:  Curr Hematol Malig Rep       Date:  2011-09       Impact factor: 3.952

Review 2.  Social adjustment across the lifespan in survivors of pediatric acute lymphoblastic leukemia (ALL): a systematic review.

Authors:  Sara Cho; Courtney Tromburg; Caitlin Forbes; Andrew Tran; Elleine Allapitan; Taryn Fay-McClymont; Kathleen Reynolds; Fiona Schulte
Journal:  J Cancer Surviv       Date:  2022-01-06       Impact factor: 4.442

3.  Health-related quality of life of survivors of childhood acute lymphoblastic leukemia: a systematic review.

Authors:  J Vetsch; C E Wakefield; E G Robertson; T N Trahair; M K Mateos; M Grootenhuis; G M Marshall; R J Cohn; J E Fardell
Journal:  Qual Life Res       Date:  2018-01-25       Impact factor: 4.147

4.  Potential gonadotoxicity of treatment in relation to quality of life and mental well-being of male survivors of childhood acute lymphoblastic leukemia.

Authors:  Mirja Erika Gunn; Päivi Maria Lähteenmäki; Leena-Riitta Puukko-Viertomies; Markus Henriksson; Risto Heikkinen; Kirsi Jahnukainen
Journal:  J Cancer Surviv       Date:  2013-04-19       Impact factor: 4.442

Review 5.  Health promotion for adolescent childhood leukemia survivors: building on prevention science and ehealth.

Authors:  Diane L Elliot; Susan J Lindemulder; Linn Goldberg; Diane D Stadler; Jennifer Smith
Journal:  Pediatr Blood Cancer       Date:  2012-10-25       Impact factor: 3.167

6.  Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.

Authors:  Stefan Essig; Qiaozhi Li; Yan Chen; Johann Hitzler; Wendy Leisenring; Mark Greenberg; Charles Sklar; Melissa M Hudson; Gregory T Armstrong; Kevin R Krull; Joseph P Neglia; Kevin C Oeffinger; Leslie L Robison; Claudia E Kuehni; Yutaka Yasui; Paul C Nathan
Journal:  Lancet Oncol       Date:  2014-06-19       Impact factor: 41.316

7.  Health-related quality of life in long-term survivors of relapsed childhood acute lymphoblastic leukemia.

Authors:  Stefan Essig; Nicolas X von der Weid; Marie-Pierre F Strippoli; Cornelia E Rebholz; Gisela Michel; Corina S Rueegg; Felix K Niggli; Claudia E Kuehni
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

8.  Severe fatigue after treatment for childhood cancer.

Authors:  Sylvia van Deuren; Amilie Boonstra; Eline van Dulmen-den Broeder; Nicole Blijlevens; Hans Knoop; Jacqueline Loonen
Journal:  Cochrane Database Syst Rev       Date:  2020-03-03

9.  Optimal chemotherapy for leukemia: a model-based strategy for individualized treatment.

Authors:  Devaraj Jayachandran; Ann E Rundell; Robert E Hannemann; Terry A Vik; Doraiswami Ramkrishna
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

10.  Prevalence and risk factors of cancer-related fatigue in childhood cancer survivors: A DCCSS LATER study.

Authors:  Sylvia van Deuren; Adriaan Penson; Eline van Dulmen-den Broeder; Martha A Grootenhuis; Margriet van der Heiden-van der Loo; Ewald Bronkhorst; Nicole M A Blijlevens; Nina Streefkerk; Jop C Teepen; Wim J E Tissing; Helena J H van der Pal; Marry M van den Heuvel-Eibrink; Birgitta A B Versluys; Dorine Bresters; Flora E van Leeuwen; Cécile M Ronckers; Leontien C M Kremer; Hans Knoop; Jacqueline J Loonen
Journal:  Cancer       Date:  2021-11-01       Impact factor: 6.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.